Recombinant Mouse Tmem88b is a 173-amino-acid transmembrane protein produced via heterologous expression systems such as HEK293 cells or E. coli. It is typically tagged with His, Fc, or Avi for purification and detection purposes . Key production specifications include:
| Parameter | Details |
|---|---|
| Molecular Weight | ~20 kDa (calculated based on 173 residues) |
| Expression System | HEK293, E. coli |
| Tags | His, Fc-Avi, or untagged variants |
| Purity | ≥85% (SDS-PAGE verified) |
| Endotoxin Levels | <1.0 EU/μg |
| Storage | -20°C to -80°C in PBS buffer; avoid freeze-thaw cycles |
| UniProt ID | Q3TYP4 (Mouse) |
Commercial variants include full-length proteins (e.g., Cat.# RFL11803MF for Mus musculus) and pre-coupled magnetic beads for pull-down assays .
Transmembrane Domains: Predicted to span the membrane once, typical of TMEM family proteins .
Conserved Motifs: Contains a Val-Trp-Val sequence at the C-terminal, implicated in binding PDZ domains of scrambled proteins to modulate Wnt/β-catenin signaling .
| Species | Amino Acid Length | Key Differences |
|---|---|---|
| Human | 163 | Shorter N-terminal region |
| Mouse | 173 | Extended C-terminal with phosphorylation sites |
| Bovine | 166 | Intermediate length |
Inhibits Wnt/β-catenin pathway activation by reducing GSK-3β phosphorylation (Ser9), observed in thyroid and bladder cancer models .
Overexpression suppresses TCF/LEF transcriptional activity, downregulating oncogenes like c-Myc and Cyclin D1 .
Modulates lipid metabolism in non-alcoholic fatty liver disease (NAFLD) models:
Enhances apoptosis in FFA-induced AML-12 hepatocytes, suggesting a protective role against steatosis .
Thyroid Cancer: Low Tmem88b expression correlates with tumor progression; restoration inhibits proliferation and invasion .
Bladder Cancer: Overexpression reduces tumor growth in xenograft models by 40% .
| Protein | Function | Interaction Score |
|---|---|---|
| TMEM179 | Membrane protein of unknown function | 0.530 |
| FAM189A1 | Lipid metabolism regulation | 0.488 |
| DZANK1 | Zinc-binding and cytoskeletal organization | 0.470 |
| Pathway | Associated Proteins |
|---|---|
| Wnt/β-catenin signaling | β-catenin, GSK-3β, TCF/LEF |
| Lipid metabolism | PPAR-α, SREBP-1c, FASN |
| Catalog # | Source | Tag | Application |
|---|---|---|---|
| TMEM88B-9433M | HEK293 | His-Fc-Avi | Protein-protein interaction studies |
| RFL11803MF | E. coli | His | Structural analysis |
| TMEM88B-9433M-B | HEK293 | Pre-coupled | High-throughput screening |
Expression: Optimized in HEK293 for post-translational modifications.
Purification: Affinity chromatography using His-tag or Fc-binding resins.
Validation: Western blotting, mass spectrometry, and functional assays (e.g., Wnt inhibition assays) .
Tmem88b (transmembrane protein 88B) is a protein-coding gene located on chromosome 4 in mice (Mus musculus). The protein contains 173 amino acids and is predicted to be localized in the cell membrane . The official full name is "transmembrane protein 88B" with gene ID 320587 . Tmem88b belongs to the transmembrane protein 88 family (IPR033355) and shares structural similarities with its paralog Tmem88. The protein contains transmembrane domains that anchor it within the cell membrane, with portions extending into both intracellular and extracellular spaces. According to structural predictions, Tmem88b features hydrophobic segments consistent with its transmembrane nature .
Tmem88b is a paralog of Tmem88, meaning they are related by gene duplication events within the mouse genome. While both belong to the same protein family (transmembrane protein 88), they exhibit distinct expression patterns and potentially different functions . Tmem88 (encoded by gene ID 67020) has been more extensively studied than Tmem88b . Sequence alignment reveals approximately 60-70% similarity between the two proteins, with conservation primarily in the transmembrane domains and certain functional motifs. The divergence between these paralogs suggests possible specialization of function, though more research is needed to fully characterize their distinct roles .
The biological function of Tmem88b is still being elucidated, but based on current research and orthologous relationships:
Tmem88b is predicted to be involved in negative regulation of the canonical Wnt signaling pathway
It may have roles in developmental processes, as indicated by expression studies in zebrafish
Its paralog Tmem88 has been better characterized functionally, providing clues to potential shared functions
Further studies, particularly those using knockout models or CRISPR-mediated targeting (as mentioned in search result #2), are needed to fully clarify its physiological role. Recent research has suggested potential connections to neuronal function, as indicated by transcriptomic studies of the medial prefrontal cortex (mPFC) .
For recombinant Tmem88b purification, consider the following strategies based on the protein's characteristics and tags:
Affinity Chromatography:
Additional Purification Steps:
Detergent Considerations:
As a transmembrane protein, inclusion of mild detergents (0.03-0.1% DDM or 0.1-0.5% CHAPS) during purification is crucial to maintain solubility and native conformation
Consider detergent exchange during purification process
Quality Control:
For optimal results, the protein should be stored in PBS buffer, either as a liquid at 4°C for short-term storage or lyophilized at -20°C to -80°C for long-term storage .
To investigate Tmem88b's role in signaling pathways, particularly the Wnt signaling pathway, consider these methodological approaches:
Wnt Signaling Analysis:
Use TOPFlash/FOPFlash luciferase reporter assays to measure changes in canonical Wnt pathway activity when recombinant Tmem88b is introduced to cells
Co-immunoprecipitation experiments to identify binding partners within the Wnt pathway
Compare signaling outputs between wild-type cells and those overexpressing or lacking Tmem88b
Protein-Protein Interaction Studies:
Proximity ligation assays to detect interactions with suspected binding partners in situ
Pull-down assays using the recombinant protein as bait
FRET-based approaches for real-time monitoring of interactions
Functional Assays:
Phosphorylation assays to monitor downstream effects on signaling cascades
Cellular localization studies using fluorescently tagged Tmem88b
Competition assays with the related Tmem88 protein to assess functional overlap
When designing these experiments, carefully control for tag effects by including appropriate controls and consider using carrier-free preparations for sensitive signaling assays to avoid BSA interference .
For ELISA-based detection of Tmem88b, follow these methodological guidelines:
Sample Preparation:
Assay Protocol:
Use commercial kits with a detection range of 0.156-10 ng/ml for optimal sensitivity
Prepare standards using recombinant Tmem88b (preferably from the same species)
Perform all incubations at room temperature unless specified otherwise
Include technical replicates (minimum triplicate) for all samples
Data Analysis:
Generate a standard curve using 4- or 5-parameter logistic regression
Ensure sample measurements fall within the linear range of the standard curve
Calculate intra- and inter-assay coefficients of variation to assess reproducibility
Critical Considerations:
Be aware that ELISA kits are optimized for native proteins; detection of recombinant proteins may vary
Sample dilution is crucial - aim for mid-range kit detection (0.5-5 ng/ml)
Validate antibody specificity using positive and negative controls
Consider matrix effects that might interfere with detection
For CRISPR-based functional studies of Tmem88b, follow these methodological approaches:
Guide RNA Design and Selection:
Use validated gRNA sequences designed to specifically target the Tmem88b gene with minimal off-target effects
When targeting Tmem88b, consider ordering at least two gRNA constructs to increase success probability
Double-check gRNA sequences against your specific mouse strain sequence, as genomic variations may affect targeting efficiency
Experimental Design for Knockout Studies:
For full gene knockout: Target early exons or multiple exons simultaneously
For specific domain analysis: Design gRNAs to create in-frame deletions of specific domains
For paralog comparison: Design parallel knockouts of both Tmem88 and Tmem88b
Delivery Methods:
For cell lines: Transfection or viral delivery of CRISPR components
For in vivo studies: Consider viral delivery or pronuclear injection for germline modification
For temporal control: Use inducible CRISPR systems (e.g., Tet-regulated Cas9)
Validation Approaches:
Genomic validation: PCR amplification and sequencing of the target region
Protein validation: Western blot or immunostaining to confirm protein loss
Functional validation: Assess changes in Wnt signaling or other suspected pathways
Controls and Considerations:
Include non-targeting gRNA controls
Address potential compensatory upregulation of the paralog Tmem88
Design rescue experiments using the recombinant Tmem88b protein or expression constructs
When analyzing results, consider the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules for regulatory compliance .
The relationship between Tmem88b and Wnt signaling is an emerging area of research, built upon evidence from its paralog Tmem88 and limited studies on Tmem88b itself:
Mechanistic Insights:
Tmem88b is predicted to be involved in negative regulation of canonical Wnt signaling, similar to Tmem88
The protein likely functions through interaction with Dishevelled (Dvl) proteins via its C-terminal domain
The transmembrane domains may anchor the protein in proximity to Wnt receptors, facilitating regulatory functions
Experimental Evidence:
Studies in zebrafish indicate expression patterns consistent with roles in developmental processes regulated by Wnt signaling
Structural predictions suggest conserved domains between Tmem88 and Tmem88b that mediate Wnt pathway interactions
Preliminary findings suggest potential tissue-specific regulation of Wnt signaling
Research Gaps and Future Directions:
Direct biochemical evidence of Tmem88b-Dvl interaction is still limited
The specific contexts (developmental stage, tissue type) where Tmem88b regulates Wnt signaling require further characterization
Potential redundancy or complementarity with Tmem88 needs systematic investigation
To further elucidate this relationship, co-immunoprecipitation studies with Wnt pathway components, TOPFlash reporter assays, and genetic studies using CRISPR-mediated knockouts would provide valuable insights.
Recent research has begun to explore Tmem88b expression in neuronal tissues and its potential implications for neuropsychiatric conditions:
Expression Patterns:
Transcriptomic analyses have detected Tmem88b expression in the medial prefrontal cortex (mPFC) of mice
Expression levels appear to be modulated by early life stress (ELS), suggesting potential involvement in stress-responsive neuronal circuits
Developmental expression patterns indicate temporal regulation during critical periods of brain development
Functional Implications:
Preliminary research suggests correlation between Tmem88b expression and social behavior phenotypes
Altered expression has been observed in conditions affecting neuronal architecture in the mPFC
Potential role in Wnt signaling within neuronal contexts may influence synaptic plasticity and neuronal morphology
Relationship to Neuropsychiatric Conditions:
Early life stress models show transcriptomic alterations that include Tmem88b pathway components
Changes in social hierarchical behavior correlate with gene expression changes that may involve Tmem88b
The protein's potential role in neuronal development through Wnt pathway regulation suggests relevance to neurodevelopmental disorders
This is an emerging field requiring further investigation through conditional knockout studies in specific neuronal populations, electrophysiological assessments, and behavioral phenotyping in animal models with altered Tmem88b expression.
Comparative analysis of Tmem88b across species reveals important evolutionary insights:
Cross-Species Conservation:
Tmem88b is conserved across vertebrates, with orthologs identified in humans (UniProt ID: A6NKF7), zebrafish, chicken, and other species
The transmembrane domains show the highest degree of conservation, suggesting functional importance
The C-terminal domain contains conserved motifs likely involved in protein-protein interactions
Sequence Homology Analysis:
| Species | Sequence Identity to Mouse Tmem88b | Protein Length | Key Differences |
|---|---|---|---|
| Human | ~85-90% | 163 aa | Shorter C-terminus |
| Rat | ~95-98% | 173 aa | Highly conserved |
| Zebrafish | ~60-65% | 221-235 aa | Extended N-terminus |
| Chicken | ~70-75% | Variable | Species-specific insertions |
| Bovine | ~80-85% | 166 aa | Minor sequence variations |
Functional Conservation:
Evolutionary Insights:
The Tmem88/Tmem88b duplication likely occurred early in vertebrate evolution
Different selective pressures across species suggest tissue-specific functional specialization
Conservation patterns highlight potentially critical functional domains for targeted studies
Evolutionary analysis provides valuable guidance for experimental design, highlighting conserved regions as targets for functional studies and suggesting that findings in mouse models may have translational relevance to human biology.
When designing mouse experiments involving Tmem88b, follow these guidelines to ensure reproducibility:
Strain Selection and Genetic Background:
Carefully choose mouse strains based on experimental needs and document strain information completely
Consider that mouse strains "are as variable as dog breeds" and have distinct characteristics that may impact results
Document genetic background thoroughly and maintain consistency across experiments
Experimental Design Framework:
Sample Size and Statistical Power:
Perform power calculations to determine appropriate sample sizes before beginning experiments
Account for potential attrition and variability between animals
Plan for adequate biological replicates (different mice) rather than just technical replicates
Controls and Variables:
Implement proper controls for all experiments (positive, negative, vehicle)
Remember that "despite being more-or-less genetically identical within a particular strain, [mice] can show phenotypic variability"
Control for environmental factors, including housing conditions, handling procedures, and time of day for experiments
Documentation and Reporting:
Document all procedures in detail, including any deviations from planned protocols
Report all results, including negative findings and unexpected observations
Include comprehensive methods sections that enable others to replicate your work
Following these guidelines will significantly improve the reproducibility and reliability of Tmem88b research in mouse models.
For optimal handling and storage of recombinant Tmem88b, follow these evidence-based protocols:
Initial Receipt and Processing:
Storage Conditions:
Working with the Protein:
Thaw aliquots rapidly at room temperature or 37°C water bath
Keep on ice when working at the bench
Centrifuge briefly before opening tubes to collect all material
Use low-binding tubes to minimize protein loss
Stability Considerations:
Product stability is typically maintained for 6 months when stored properly
Activity loss should be less than 5% within the expiration date under appropriate storage conditions
Consider adding stabilizers like 50% glycerol for freeze-thaw protection
BSA addition (0.1-1%) may improve stability for dilute solutions, unless using for applications where BSA would interfere
Quality Control:
Periodically verify protein integrity using SDS-PAGE
For functional studies, include activity controls with each experiment
Document all handling procedures and storage times
Following these protocols will help maintain the integrity and activity of recombinant Tmem88b for your research applications.
When troubleshooting recombinant Tmem88b expression or functional issues, follow this systematic approach:
Expression Problems:
| Problem | Potential Causes | Troubleshooting Approaches |
|---|---|---|
| Low yield | Toxicity to expression host; poor codon optimization; protein degradation | Try different expression systems; optimize codons; add protease inhibitors; lower induction temperature |
| Inclusion bodies | Improper folding; overexpression | Reduce expression rate; co-express chaperones; optimize lysis conditions; consider refolding protocols |
| Proteolytic degradation | Host proteases; sample handling | Add protease inhibitors; optimize purification speed; check storage conditions |
| Poor solubility | Transmembrane nature of protein | Include appropriate detergents; try different solubilization buffers; consider fusion tags that enhance solubility |
Purification Challenges:
For affinity tag issues: Verify tag accessibility; adjust imidazole concentrations for His-tag purification
For aggregation: Try different detergents; optimize buffer composition; consider on-column folding
For co-purifying contaminants: Add washing steps with increased salt or detergent; consider secondary purification methods
For low purity: Implement multi-step purification strategy to achieve >80% purity
Functional Assays Troubleshooting:
No activity: Verify protein folding; check buffer compatibility; ensure proper post-translational modifications
Variable results: Standardize protein concentration determination; use fresh aliquots; control experimental conditions
Interference issues: Use carrier-free preparations for sensitive assays ; control for tag effects
Systematic Approach:
Document all variables and changes systematically
Test one parameter at a time
Include appropriate positive and negative controls
Consider consulting specific guidelines for transmembrane protein work
Validation Methods:
Remember that as a transmembrane protein, Tmem88b presents specific challenges that may require specialized approaches compared to soluble proteins.
Research with recombinant Tmem88b must comply with various regulatory and biosafety requirements:
NIH Guidelines Compliance:
Research with recombinant Tmem88b falls under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
Experiments require Institutional Biosafety Committee (IBC) approval before initiation
The specific section that applies depends on the nature of your work:
Section III-D for standard recombinant protein expression in laboratory strains
Section III-C for work involving human subjects
Section III-B for experiments involving toxin molecules
Biosafety Level Determinations:
Institutional Requirements:
Submit protocols to your Institutional Biosafety Committee
Ensure all personnel have appropriate training
Document risk assessments and containment procedures
Follow institutional waste management protocols
International Considerations:
Special Precautions:
Compliance with these regulations not only ensures legal operation but also promotes safe and responsible research practices.